Audrey Kunin, Chief Product Officer at NovaBay Pharmaceuticals, Inc. (NBY), sold 5,960 shares at $2.10 ($13K) on 2022-11-21, disclosed to the SEC on 2022-12-05.
Open-market sale of $13k NBY by Chief Product Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBY | BUY | 2021-12-07 | $47K | — | Filing → |
| NBY | BUY | 2021-12-06 | $252K | — | Filing → |
| NBY | BUY | 2021-12-03 | $7K | — | Filing → |